Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: NRM004
MIFTS: 49

Neuroma

Categories: Cancer diseases, Neuronal diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Neuroma

About this section

MalaCards integrated aliases for Neuroma:

Name: Neuroma 12 55 44 15 73

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:2001
MeSH 44 D009463
NCIt 50 C3275
SNOMED-CT 68 25169009
UMLS 73 C0027858
Sources

Summaries for Neuroma

About this section
Disease Ontology : 12 A nervous system benign neoplasm that is characterized as a nerve tissue tumor.

MalaCards based summary : Neuroma is related to acoustic neuroma and multiple mucosal neuroma. An important gene associated with Neuroma is ANK3 (Ankyrin 3), and among its related pathways/superpathways are Neuroscience and Spinal Cord Injury. The drugs Bupivacaine and Triamcinolone have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and testes, and related phenotypes are Increased proliferation and behavior/neurological

Wikipedia : 76 A neuroma (/nj�?�?�?ro�?m�?/; plural: neuromata or neuromas) is a growth or tumor of nerve tissue. ... more...

Sources

Related Diseases for Neuroma

About this section

Diseases related to Neuroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 255)
# Related Disease Score Top Affiliating Genes
1 acoustic neuroma 34.3 BICRA NF2 TGFB1
2 multiple mucosal neuroma 33.7 ENO2 RET
3 multiple endocrine neoplasia, type iib 33.0 CALCA GDNF RET
4 multiple endocrine neoplasia 30.4 CALCA GDNF RET
5 hydrocephalus 30.3 ENO2 GFAP NGF TGFB1
6 hemangioma 30.1 ENO2 FGF2 RET
7 plexiform neurofibroma 30.0 ANK3 NF2
8 ependymoma 29.8 ENO2 GFAP NF2 S100B
9 pheochromocytoma 29.7 CALCA ENO2 GDNF NGF RET
10 thyroid carcinoma, familial medullary 29.6 CALCA ENO2 GDNF RET
11 malignant peripheral nerve sheath tumor 29.6 NF2 S100B SMARCB1
12 medullomyoblastoma 29.5 ENO2 GFAP SMARCB1
13 neurilemmoma 29.5 ENO2 GFAP NF2 S100B SMARCB1
14 neuroma biliary tract 12.0
15 neurofibromatosis, type iv, of riccardi 12.0
16 neurofibromatosis, type ii 11.2
17 neurofibromatosis, type i 11.2
18 klumpke paralysis 11.2
19 erb-duchenne and dejerine-klumpke palsies 11.0
20 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.4
21 headache 10.3
22 meningothelial meningioma 10.3 ENO2 NF2
23 cerebral convexity meningioma 10.3 GFAP NF2
24 intraventricular meningioma 10.3 GFAP NF2
25 primitive neuroectodermal tumor of the cervix uteri 10.3 ENO2 GFAP
26 bednar tumor 10.3 ENO2 S100B
27 gemistocytic astrocytoma 10.3 GFAP S100B
28 cerebellar medulloblastoma 10.3 ENO2 GFAP
29 fibrous meningioma 10.3 NF2 S100B
30 syringocystadenoma papilliferum 10.3 GFAP S100B
31 ossifying fibromyxoid tumor 10.3 ENO2 S100B
32 central nervous system primitive neuroectodermal neoplasm 10.3 ENO2 GFAP
33 clear cell ependymoma 10.3 ENO2 GFAP
34 facial paralysis 10.3
35 chordoid meningioma 10.3 GFAP S100B
36 spinal cancer 10.2 GFAP NF2
37 askin's tumor 10.2 ENO2 NGF
38 dysembryoplastic neuroepithelial tumor 10.2 GFAP S100B
39 spindle cell rhabdomyosarcoma 10.2 GFAP S100B
40 plexiform schwannoma 10.2 ENO2 GFAP NF2
41 benign ependymoma 10.2 ENO2 GFAP NF2
42 middle cerebral artery infarction 10.2 ENO2 S100B
43 chordoid glioma 10.2 GFAP NF2 S100B
44 anaplastic ependymoma 10.2 GFAP NF2 S100B
45 intracranial cysts 10.2 ENO2 GFAP S100B
46 cerebrospinal fluid leak 10.2
47 subependymal glioma 10.2 ENO2 GFAP
48 pineocytoma 10.2 ENO2 GFAP S100B
49 papillary ependymoma 10.2 ENO2 GFAP S100B
50 granular cell tumor 10.2 ENO2 GFAP S100B

Graphical network of the top 20 diseases related to Neuroma:



Diseases related to Neuroma
Sources

Symptoms & Phenotypes for Neuroma

About this section

GenomeRNAi Phenotypes related to Neuroma according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased proliferation GR00094-A 8.62 NF2 SMARCB1

MGI Mouse Phenotypes related to Neuroma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.3 ANK3 ENO2 FGF2 GDNF GFAP NF2
2 homeostasis/metabolism MP:0005376 10.15 FGF2 GFAP LZTR1 NF2 NGF RET
3 growth/size/body region MP:0005378 10.1 ENO2 GDNF GFAP NF2 NGF RET
4 cardiovascular system MP:0005385 10.09 FGF2 GDNF GFAP NGF RET SCN10A
5 mortality/aging MP:0010768 10.06 ANK3 FGF2 GDNF GFAP LZTR1 NF2
6 muscle MP:0005369 9.8 FGF2 GDNF GFAP NGF RET SMARCB1
7 nervous system MP:0003631 9.77 ANK3 ENO2 FGF2 GDNF GFAP NF2
8 neoplasm MP:0002006 9.63 FGF2 NF2 RET SMARCB1 TGFB1 TRPV1
9 vision/eye MP:0005391 9.17 FGF2 GFAP NF2 NGF SEMA3F SMARCB1
Sources

Drugs & Therapeutics for Neuroma

About this section

Drugs for Neuroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 162)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
2
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
3
Mepivacaine Approved, Vet_approved Phase 4 96-88-8 4062
4 Gentamicins Phase 4,Not Applicable
5 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
6 Anti-Infective Agents Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
7 Anesthetics Phase 4,Phase 1,Not Applicable,Early Phase 1
8 Anesthetics, Local Phase 4,Phase 1,Not Applicable,Early Phase 1
9 Central Nervous System Depressants Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
10 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
11 Immunosuppressive Agents Phase 4,Phase 2,Phase 1,Early Phase 1
12 Hormone Antagonists Phase 4,Not Applicable
13 Immunologic Factors Phase 4,Phase 2,Phase 1,Early Phase 1
14 Anti-Inflammatory Agents Phase 4,Phase 2,Not Applicable
15 Hormones Phase 4,Not Applicable
16 glucocorticoids Phase 4,Not Applicable
17 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Not Applicable
18 triamcinolone acetonide Phase 4
19 Triamcinolone hexacetonide Phase 4
20 Triamcinolone diacetate Phase 4
21
Mechlorethamine Approved, Investigational Phase 3,Phase 2 51-75-2 4033
22
Ifosfamide Approved Phase 3,Phase 2 3778-73-2 3690
23
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
24
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 6055-19-2, 50-18-0 2907
25
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
26 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Early Phase 1
27
Isophosphamide mustard Phase 3,Phase 2 0
28 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
29 Alkylating Agents Phase 3,Phase 2,Phase 1
30 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
31 Protein Kinase Inhibitors Phase 2, Phase 3,Early Phase 1
32 Imatinib Mesylate Phase 2, Phase 3 220127-57-1 123596
33
Everolimus Approved Phase 2,Phase 1,Early Phase 1 159351-69-6 6442177
34
Sirolimus Approved, Investigational Phase 2,Phase 1,Early Phase 1 53123-88-9 46835353 6436030 5284616
35
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
36
Bevacizumab Approved, Investigational Phase 2,Phase 1 216974-75-3
37
Capsaicin Approved Phase 2,Phase 1 404-86-4 1548943
38
Morphine Approved, Investigational Phase 2 57-27-2 5288826
39
Mexiletine Approved, Investigational Phase 2 31828-71-4 4178
40
Xylometazoline Approved, Investigational Phase 1, Phase 2 526-36-3 5709
41
Dacarbazine Approved, Investigational Phase 2,Phase 1 4342-03-4 5351166
42
Nicotinamide Approved, Investigational Phase 2 98-92-0 936
43
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
44
Dasatinib Approved, Investigational Phase 2 302962-49-8 3062316
45
Lenograstim Approved, Investigational Phase 2 135968-09-1
46
Etoposide Approved Phase 2 33419-42-0 36462
47
Acetylcholine Approved Phase 2,Not Applicable 51-84-3 187
48
Aspirin Approved, Vet_approved Phase 2 50-78-2 2244
49
Axitinib Approved, Investigational Phase 2 319460-85-0 6450551
50
Mesna Approved, Investigational Phase 2 3375-50-6 598

Interventional clinical trials:

(show top 50) (show all 153)
# Name Status NCT ID Phase Drugs
1 Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function Unknown status NCT02379754 Phase 4 Gentamicins
2 Pathophysiology of Post Amputation Pain Completed NCT01632709 Phase 4 Bupivacaine;Placebo
3 A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options Completed NCT00948025 Phase 4
4 Blind and Ultrasound Guided Injection in Morton Neuroma Recruiting NCT03046108 Phase 4 blind injection of Mepivacaine;blind injection of Triamcinolone;guided injection of mepivacaine;guided injection of Triamcinolone
5 Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function Recruiting NCT02415257 Phase 4 Gentamicin
6 Intranasal Neurostimulation in Ameliorating Symptoms of Neuropathic Corneal Pain Recruiting NCT03674892 Phase 4
7 Stereotactic Radiation in Vestibular Schwannoma Unknown status NCT01449604 Phase 3
8 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
9 Cyberknife Radiosurgery for Patients With Neurinomas Recruiting NCT02055859 Phase 3
10 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Suspended NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
11 Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors Terminated NCT00427583 Phase 2, Phase 3 imatinib mesylate
12 SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors Unknown status NCT01661283 Phase 2 everolimus;bevacizumab
13 A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) Completed NCT02283957 Phase 2 CNTX-4975
14 ALGRX 4975 in the Treatment of Patients With Morton's Neuroma Completed NCT00130962 Phase 2 ALGRX 4975
15 A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) Completed NCT02678793 Phase 2 CNTX-4975
16 Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) Completed NCT01207687 Phase 2
17 Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Completed NCT00973739 Phase 2 Lapatinib
18 Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2 Completed NCT00004437 Phase 2
19 Efficacy of Opioids and Mexiletine for the Treatment of Postamputation Pain Completed NCT00383682 Phase 2 morphine and mexiletine
20 Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Completed NCT02104323 Phase 2 Endostatin
21 Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients Completed NCT01490476 Phase 2 RAD001
22 Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 Completed NCT01419639 Phase 2 Everolimus (RAD001) , Afinitor®
23 SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) Completed NCT02008877 Phase 1, Phase 2 ganetespib;Sirolimus
24 Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01653028 Phase 2 Alisertib
25 Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma Completed NCT01614795 Phase 2 Temsirolimus
26 Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01154452 Phase 1, Phase 2 Gamma-Secretase Inhibitor RO4929097;Vismodegib
27 Sorafenib and Dacarbazine in Soft Tissue Sarcoma Completed NCT00837148 Phase 2 Sorafenib and Dacarbazine
28 Trial of Dasatinib in Advanced Sarcomas Completed NCT00464620 Phase 2 Dasatinib
29 Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors Completed NCT00304083 Phase 2 doxorubicin hydrochloride;etoposide;ifosfamide
30 S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor Completed NCT00068367 Phase 2 erlotinib hydrochloride
31 RGD PET/MRI in Sporadic Vestibular Schwannoma Recruiting NCT03393689 Phase 2 One injection of 68Ga-NODAGA-E[c(RGDyK)]2
32 Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Recruiting NCT01199978 Phase 2
33 Study of Aspirin in Patients With Vestibular Schwannoma Recruiting NCT03079999 Phase 2 Aspirin;Placebo
34 Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas Recruiting NCT03231306 Phase 2 Binimetinib
35 Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Recruiting NCT02934256 Phase 2 Icotinib
36 Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Recruiting NCT02129647 Phase 2 Axitinib
37 Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Recruiting NCT03095248 Phase 2 Selumetinib
38 Hypofractionated Radiotherapy With Sequential Chemotherapy in Primary Unresectable or Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Recruiting NCT03651375 Phase 2 Sequential chemotherapy - 3 courses of AI
39 Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers Recruiting NCT03215511 Phase 1, Phase 2 LOXO-195
40 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
41 A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Recruiting NCT02691026 Phase 2 Pembrolizumab
42 PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Recruiting NCT02584647 Phase 1, Phase 2 PLX3397;Sirolimus
43 Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Recruiting NCT02584309 Phase 2 Dexrazoxane;Doxorubicin;Olaratumab
44 Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Recruiting NCT01532687 Phase 2 Gemcitabine Hydrochloride;Pazopanib Hydrochloride
45 Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma Active, not recruiting NCT01345136 Phase 2 RAD001, everolimus
46 Axillary Reverse Mapping Active, not recruiting NCT00572481 Phase 2
47 AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas Active, not recruiting NCT02831257 Phase 2 AZD2014
48 Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Active, not recruiting NCT01767792 Phase 2 Bevacizumab
49 Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas Active, not recruiting NCT01125046 Phase 2
50 Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Active, not recruiting NCT02601209 Phase 1, Phase 2 Pazopanib Hydrochloride;Sapanisertib

Search NIH Clinical Center for Neuroma

Cochrane evidence based reviews: neuroma

Sources

Genetic Tests for Neuroma

About this section
Sources

Anatomical Context for Neuroma

About this section

MalaCards organs/tissues related to Neuroma:

41
Brain, Bone, Testes, Lung, Spinal Cord, Pituitary, Thyroid
Sources

Publications for Neuroma

About this section

Articles related to Neuroma:

(show top 50) (show all 1611)
# Title Authors Year
1
Vestibular Traumatic Neuroma Following Temporal Bone Fracture. ( 30531646 )
2019
2
Risk of posterior semicircular canal trauma when using a retrosigmoid approach for acoustic neuroma surgery and role of endoscopy: An imaging study. ( 29493720 )
2018
3
Painful Terminal Neuroma Prevention by Capping PRGD/PDLLA Conduit in Rat Sciatic Nerves. ( 29938170 )
2018
4
Acoustic Neuroma Treated with Stereotactic Radiosurgery: Follow-up of 335 Patients. ( 29715569 )
2018
5
Mechanical Metatarsalgia as a Risk Factor for Relapse of Morton's Neuroma After Ultrasound-Guided Alcohol Injection. ( 29779991 )
2018
6
Patient Decision Making in Vestibular Schwannoma: A Survey of the Acoustic Neuroma Association. ( 29436268 )
2018
7
Superficial Peroneal Nerve to Deep Peroneal Nerve Transfer With Allograft Conduit for Neuroma in Continuity. ( 29685562 )
2018
8
Nonspecific Chronic Anteromedial Knee Pain Neuroma as a Cause of Infrapatellar Pain Syndrome: Case Study and Literature Review. ( 29404377 )
2018
9
Solitary Circumscribed Neuroma: Dermoscopic clues to facilitate diagnosis. ( 29666696 )
2018
10
Increased sensibility to acute acoustic and blast trauma among patients with acoustic neuroma. ( 29184217 )
2018
11
Risk factors and the associated cutoff values for failure of corticosteroid injection in treatment of Morton's neuroma. ( 29230531 )
2018
12
Plantar Pressure Measurements and Geometric Analysis of Patients With and Without Morton's Neuroma. ( 29641258 )
2018
13
Cochlea-sparing acoustic neuroma treatment with 4I8 radiation therapy. ( 29904732 )
2018
14
Increased Hospital Surgical Volume Reduces Rate of 30- and 90-Day Readmission After Acoustic Neuroma Surgery. ( 29889284 )
2018
15
Acoustic neuroma quality of life: are we missing the point? ( 29948270 )
2018
16
The medium and long-term effect of electrophysiologic monitoring on the facial nerve function in minimally invasive surgery treating acoustic neuroma. ( 29563978 )
2018
17
Epithelial sheath neuroma with extension to the subcutis. ( 29797343 )
2018
18
Long-term outcome after Gamma Knife radiosurgery for acoustic neuroma of all Koos grades: a single-center study. ( 29498575 )
2018
19
Painful Neuroma Treatment of the Supraorbital Nerve and Forehead Neurotization Using Human Cadaveric Nerve Allograft. ( 29521743 )
2018
20
Neuroma Implantation into Long Bones: Clinical Foundation for a Novel Osseointegrated Peripheral Nerve Interface. ( 29922565 )
2018
21
Ophthalmic Complications Following Acoustic Neuroma Resection. ( 29253289 )
2018
22
Endobronchial Mucosal Neuroma with Sarcoidosis. ( 29394980 )
2018
23
The impact of acoustic neuroma on long-term quality-of-life outcomes in the United Kingdom. ( 29330600 )
2018
24
Bilateral Nonsynchronous Pacinian Corpuscle Neuroma. ( 29627280 )
2018
25
Regenerative Peripheral Nerve Interface for Management of Postamputation Neuroma. ( 29847613 )
2018
26
Novel experimental surgical strategy to prevent traumatic neuroma formation by combining a 3D-printed Y-tube with an autograft. ( 29424651 )
2018
27
Analysis of regeneration- and myelination-associated proteins in human neuroma in continuity and discontinuity. ( 29656327 )
2018
28
Incidence and associations of painful neuroma in a contemporary cohort of lower-limb amputees. ( 29654613 )
2018
29
Transcanal Transpromontorial Acoustic Neuroma Surgery: Results and Facial Nerve Outcomes. ( 29227438 )
2018
30
Patterns of stereotactic radiotherapy utilization and fractionation for acoustic neuroma in the United States. ( 29988251 )
2018
31
Trough-Shaped Audiograms Are Common in Patients with Acoustic Neuroma and Sudden Sensorineural Hearing Loss. ( 30021194 )
2018
32
Pearls for the middle fossa approach in acoustic neuroma surgery. ( 30024419 )
2018
33
Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma. ( 30025986 )
2018
34
Electrical stimulation-based nerve location prediction for cranial nerve VII localization in acoustic neuroma surgery. ( 30106250 )
2018
35
Non-contrast magnetic resonance imaging for monitoring patients with acoustic neuroma. ( 30117408 )
2018
36
Perioperative Care of the Patient With Acoustic Neuroma. ( 30117553 )
2018
37
Multi-option therapy vs observation for small acoustic neuroma: hearing-focused management. ( 30197430 )
2018
38
The Method for Placement of an Intraoperative Continuous Facial Nerve Stimulating Electrode in Acoustic Neuroma Surgery: Technical Note. ( 30249920 )
2018
39
Primary glioblastoma of the cerebellopontine angle in an adult mimicking an acoustic neuroma. ( 30347301 )
2018
40
Long-Term Tumor Control Rates Following Gamma Knife Radiosurgery for Acoustic Neuroma. ( 30447465 )
2018
41
Incidence of Prolonged Systemic Steroid Treatment after Surgery for Acoustic Neuroma and Its Implications. ( 30456025 )
2018
42
Hearing preservation in small acoustic neuroma: observation or active therapy? Literature review and institutional experience. ( 30535851 )
2018
43
Hypercellular Encapsulated Neuroma Imitating Desmoplastic Melanoma. ( 30531539 )
2018
44
Ultrasound-Guided Percutaneous Radiofrequency for the Treatment of Morton's Neuroma. ( 28956110 )
2018
45
Facial nerve neuroma in the geniculate ganglion extending into the internal auditory canal: A case report. ( 28988846 )
2018
46
Deep Transverse Metatarsal Ligament Transection in Morton's Neuroma Excision: A Cadaveric Study Examining Effects on Metatarsal Alignment. ( 29047294 )
2018
47
Traumatic subungual neuroma. ( 29055068 )
2018
48
Traumatic bile duct neuroma diagnosed by boring biopsy with cholangioscopy. ( 29102735 )
2018
49
Ultrasound-Guided Hyaluronic Acid Injection for the Management of Morton's Neuroma. ( 29153007 )
2018
50
Surgical interventions for the treatment of painful neuroma: a comparative meta-analysis. ( 29189515 )
2018
Sources

Variations for Neuroma

About this section
Sources

Expression for Neuroma

About this section
Search GEO for disease gene expression data for Neuroma.
Sources

Pathways for Neuroma

About this section

Pathways related to Neuroma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Neuroscience 4
11.76 CALCA ENO2 GFAP NF2 NGF RET
2
Spinal Cord Injury 1
11.51 GDNF GFAP TGFB1
3
Neural Stem Cell Differentiation Pathways and Lineage-specific Markers 65
11.25 FGF2 GDNF GFAP NGF S100B
4
Lung fibrosis 1
11.13 CALCA FGF2 TGFB1
Sources

GO Terms for Neuroma

About this section

Cellular components related to Neuroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.8 CALCA ENO2 FGF2 NGF S100B SEMA3F
2 neuronal cell body GO:0043025 9.43 CALCA ENO2 RET S100B TGFB1 TRPV1
3 SWI/SNF complex GO:0016514 9.16 BICRA SMARCB1
4 axon GO:0030424 9.1 ANK3 CALCA NGF RET SCN10A TGFB1

Biological processes related to Neuroma according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of apoptotic process GO:0043065 9.81 NGF S100B TGFB1 TRPV1
2 regulation of signaling receptor activity GO:0010469 9.65 CALCA FGF2 GDNF NGF TGFB1
3 MAPK cascade GO:0000165 9.62 FGF2 GDNF RET TGFB1
4 negative regulation of ossification GO:0030279 9.54 CALCA TGFB1
5 positive regulation of branching involved in ureteric bud morphogenesis GO:0090190 9.52 GDNF TGFB1
6 hyaluronan catabolic process GO:0030214 9.49 FGF2 TGFB1
7 detection of temperature stimulus involved in sensory perception of pain GO:0050965 9.48 CALCA TRPV1
8 negative regulation of cell-cell adhesion GO:0022408 9.46 NF2 TGFB1
9 nerve development GO:0021675 9.43 NGF SEMA3F
10 lens fiber cell differentiation GO:0070306 9.4 NF2 TGFB1
11 enteric nervous system development GO:0048484 9.37 GDNF RET
12 neural crest cell migration GO:0001755 9.33 GDNF RET SEMA3F
13 ureteric bud development GO:0001657 9.13 GDNF RET TGFB1
14 response to pain GO:0048265 8.8 CALCA RET TRPV1

Molecular functions related to Neuroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 Ras guanyl-nucleotide exchange factor activity GO:0005088 9.13 FGF2 GDNF RET
2 growth factor activity GO:0008083 8.92 FGF2 GDNF NGF TGFB1
Sources

Sources for Neuroma

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....